Home Administrative Billing & Reimbursement BlueCard® Health and Wellness Medical PEAR portal Pharmacy Products Quality Management

​FDA withdraws approval of preterm prevention drug Makena®

May 5, 2023

​On April 6, 2023, the FDA withdrew the approval and distribution of the drug Makena® (hydroxyprogesterone caproate) and its generics. Effective immediately, Independence Blue Cross will not accept new authorizations for Makena.

Makena was approved by the FDA under the accelerated approval pathway in 2011. The product was manufactured to prevent premature (preterm) birth in parents who experienced preterm birth in earlier pregnancies.

The FDA based its decision on the manufacturer demonstrating an intermediate clinical endpoint that was reasonably likely to predict clinical benefit. The agency's approval, however, also included a requirement that the manufacturer conduct a post-marketing confirmatory study. The ensuing confirmatory study did not verify clinical benefit.

How does this affect our members?

Current members on Makena should consult directly with their treating health care provider about their treatment options given the Makena's removal from the market.

Medical Policy update

The Medical Policy for Makena will be archived, and the policy position will be Not Medically Necessary based on the information from the FDA.    

For more information

For more information on this decision, the complete statement on the U.S. market withdrawal of Makena can be found on the FDA website.​


This content was prepared for the Provider News Center and may not be reproduced in any way without the express written permission of Independence Blue Cross. Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association.
Connect with us     Facebook     Twitter     Flickr     YouTube     Walk the Talk    Independence Pinterest    Independence LinkedIn    Independence Instagram Site Map        Anti-Fraud        Privacy Policy        Legal        Disclaimer
© 2023 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.